[Newsletter] XENONEWS
June 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
More[Press Alert] Safety and efficacy results of LIS1
June 2022. # Download our press information (english version) # Télécharger notre...
More[Press Information] XENOTHERA presents LIS1 results at the American Transplant Congress (ATC) in Boston
May 2022. # Download our press information (english version) # Télécharger notre...
More[ Press Information ] APPOINTMENTS
April 2022. # Download our press information (english version) # Télécharger notre...
More[Newsletter] XENONEWS
February 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
More[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.
January 2022. # Download our press information (english version) # Télécharger notre...
More[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody
December 2021. # Download our press information (english version) # Télécharger notre...
More[Newsletter] XENONEWS
December 2021. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
More[ Press Information ]The French biotech XENOTHERA awarded Start-Up of the Year for the Western region.
# Download our press information (english version) # Télécharger notre information presse...
More